Cross-Market Thesis

Skin cancer vaccine approval delayed past 2027

This trader is expressing a view that Skin cancer vaccine FDA approved by December 31, 2027? are correlated outcomes, committing $1,110 to this thesis across 1 prediction market on Polymarket.

S
Sharp_0x2779878% win rate

Total

$1,110

Markets

1

Positions

  1. 1Skin cancer vaccine FDA approved by December 31, 2027?
    $1,110 @ 37¢
Skin cancer vaccine approval delayed past 2027 — Cross-Market Analysis | PolySpotter